Bluebird Bio - Stock Price History | BLUE

Historical daily share price chart and data for Bluebird Bio since 2021 adjusted for splits. The latest closing stock price for Bluebird Bio as of October 22, 2021 is 20.80.
  • The all-time high Bluebird Bio stock closing price was 233.05 on March 12, 2018.
  • The Bluebird Bio 52-week high stock price is 59.32, which is 185.2% above the current share price.
  • The Bluebird Bio 52-week low stock price is 17.14, which is 17.6% below the current share price.
  • The average Bluebird Bio stock price for the last 52 weeks is 32.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bluebird Bio Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 60.5399 86.3700 98.0400 40.3900 43.2700 -50.69%
2019 117.5488 99.5000 162.4500 72.5000 87.7500 -11.54%
2018 162.3411 181.9000 233.0500 91.2500 99.2000 -44.30%
2017 109.2424 61.8500 201.8000 61.8500 178.1000 188.65%
2016 52.1084 63.4700 78.9500 36.2000 61.7000 -3.92%
2015 119.3100 91.2600 194.2500 52.2500 64.2200 -29.98%
2014 33.9973 20.8700 93.6600 17.6900 91.7200 337.18%
2013 25.1425 26.9100 35.0000 17.5300 20.9800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.406B $0.251B
Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76